Pathological, biological and clinical characteristics, and surgical management, of elderly women with breast cancer

Critical Reviews in Oncology/hematology
Annamaria MolinoGian Luigi Cetto

Abstract

For this retrospective study, we divided 3814 patients with invasive operable breast cancer into five groups based on their age at diagnosis. Univariate analysis showed that the elderly women had larger tumours with more axillary node involvement and lymphovascular invasion, more estrogen- and progesterone-positive tumours, lower grades and proliferative indices, and were less likely to be c-erbB2 positive. They were more likely to have been diagnosed in a symptomatic state and to have undergone mastectomy, and less likely to have undergone mammary reconstruction or axillary dissection, or to have a family history of breast cancer. The multinomial regression model showed that pT, pN, ER, PgR, the type of diagnosis, and a family history were independently associated with each other. The results of this study show that elderly women are more likely to have larger and more frequently N+ tumours, but these are biologically less aggressive and usually seem to receive less invasive surgical treatment.

References

Nov 1, 1990·The Australian and New Zealand Journal of Surgery·S F HurleyS A Hart
Nov 1, 1989·American Journal of Public Health·J G ZapkaH L Greene
Aug 1, 1988·Journal of the American Geriatrics Society·S E RadeckiJ C Beck
Jul 17, 1995·International Journal of Cancer. Journal International Du Cancer·P BonnierL Piana
Jun 1, 1993·Cancer·P G PeerA L Verbeek
Feb 1, 1996·International Journal of Radiation Oncology, Biology, Physics·T E MerchantP Borgen
Apr 13, 1999·American Journal of Clinical Oncology·L J SolinH B Kessler
Mar 25, 2000·Endocrine-related Cancer·M G DaidoneR Silvestrini
Apr 6, 2000·Journal of the National Cancer Institute·S G DiabG M Clark
Aug 14, 2001·Critical Reviews in Oncology/hematology·S Franceschi, C La Vecchia
Nov 27, 2001·American Journal of Surgery·B J GrubeA E Giuliano
Mar 14, 2003·Critical Reviews in Oncology/hematology·Maria Grazia DaidoneSilvia Veneroni
Aug 9, 2003·The New England Journal of Medicine·Umberto VeronesiRoberto Gennari

❮ Previous
Next ❯

Citations

Oct 16, 2010·Archives of Gynecology and Obstetrics·Paraskevi ChatzidakiIoannis Mylonas
Sep 14, 2007·Breast Cancer Research and Treatment·Roberto Gennari, Riccardo A Audisio
Nov 26, 2010·Annals of Surgical Oncology·Paraskevi ChatzidakiIoannis Mylonas
Jun 28, 2011·The Oncologist·Jean-Philippe SpanoGilles Freyer
Jan 30, 2014·Journal of Geriatric Oncology·Heather S Laird-FickNikolay V Dimitrov
May 14, 2014·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Rebecca A ShelbyGretchen G Kimmick
Jun 7, 2011·Clinics in Geriatric Medicine·Beatriz Korc-GrodzickiRachelle E Bernacki
Aug 14, 2010·Clinical Breast Cancer·Edoardo BotteriNicole Rotmensz
Apr 8, 2009·Critical Reviews in Oncology/hematology·Diana CrivellariAndrea Veronesi
May 27, 2008·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Mariella Mannino, John R Yarnold
Sep 18, 2007·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·W J LouwmanA C Voogd
Aug 8, 2007·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Maryska L G Janssen-HeijnenJan Willem W Coebergh
Mar 13, 2016·Breast Cancer Research and Treatment·Charla C EngelsGerrit Jan Liefers
Oct 13, 2009·Histopathology·Gary M TseTakuya Moriya
Jul 16, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Xavier PivotDavid W Miles
Aug 2, 2014·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·T BatesG Lawrence
May 11, 2013·Cancer Treatment Reviews·Joan AlbanellCésar A Rodríguez
Nov 11, 2008·Critical Reviews in Oncology/hematology·Bruno CutuliRenaud Fay
Oct 18, 2016·The Indian Journal of Medical Research·Abhijit ChakrabortyAshis Mukhopadhyay
May 20, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hans WildiersPatrick Neven
May 10, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Diana CrivellariHyman Muss
Aug 15, 2017·Breast Cancer Research and Treatment·M LodiC Mathelin
Oct 17, 2015·Journal of breast cancer·Fotinos-Ioannis D DimitrakopoulosHaralabos P Kalofonos
Jan 4, 2007·The Journal of Pathology·R A Walker, C V Martin
Aug 13, 2009·Expert Review of Anticancer Therapy·Phuong Tran, Ian S Fentiman
Jun 4, 2020·The British Journal of Surgery·J L MorganUNKNOWN Bridging the Age Gap Trial Management Team
Apr 7, 2020·Breast Disease·Suk Jung Kim, Young Mi Park
Jan 1, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Aboulfazl AfsharfardEisa Tahmasbpour
Oct 9, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Ebru Sen OranAtilla Soran
Jun 24, 2018·Irish Journal of Medical Science·Chwanrow Karim BabanJames Geraghty
Mar 28, 2018·BioMed Research International·Suk-Young Lee, Jae Hong Seo

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.